NDC product
Voltaren Arthritis Pain
NDC 0067-8152 · Haleon US Holdings LLC
Key facts
| Product NDC | 0067-8152 |
|---|---|
| Proprietary name | Voltaren |
| Nonproprietary name | diclofenac sodium |
| Substances | DICLOFENAC SODIUM |
| Dosage form | GEL |
| Route | TOPICAL |
| Labeler | Haleon US Holdings LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA022122 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC] |
| Marketing start | May 13, 2020 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: